Skip to main content
TipRanks
Go Ultimate75% OFF

Prelude Therapeutics (PRLD) Q4 2024 Earnings Report

196 Followers

PRLD Q4 2024 EPS Results

Actual EPS
-$0.37
Consensus EPS
-$0.46
Beat/Miss
Beat by +$0.09
One Year Ago EPS
-$0.45

PRLD Q4 2024 Revenue Results

Actual Revenue
$4.00M
Expected Revenue
$0
Beat/Miss
Beat by +$4.00M
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2024
Date
03/10/2025
Time
Before Open
Conference Call
Monday, March 10, 2025
PRLD Upcoming Earnings

Prelude Therapeutics's next earnings date is estimated for March 16, 2027, based on past reporting schedules.

Q4 2024 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

PRLD Earnings History

PRLD earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 16, 20272026 (Q4)―--0.2――
Nov 05, 20262026 (Q3)0.01--0.26―
Aug 19, 20262026 (Q2)-0.20-0.14-0.4165.85% (+0.27)
May 12, 20262026 (Q1)-0.25-0.13-0.4269.05% (+0.29)
Mar 10, 20262025 (Q4)-0.03-0.20-0.3745.95% (+0.17)
Nov 12, 20252025 (Q3)-0.37-0.26-0.4339.53% (+0.17)
Aug 14, 20252025 (Q2)-0.44-0.41-0.4610.87% (+0.05)
May 06, 20252025 (Q1)-0.47-0.42-0.420.00% (+0.00)
Mar 10, 20252024 (Q4)-0.46-0.37-0.4517.78% (+0.08)
Nov 06, 20242024 (Q3)-0.47-0.43-0.454.44% (+0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed